Healthtech Startups

Kalderos describes its company culture, values, and diversity and inclusion initiatives, including a women-in-tech program.

4 investors

Kallyope is a biotechnology company founded by neuroscientists that discovers and develops novel therapeutics targeting neural networks, with a lead candidate in pivotal studies for acute migraine treatment and metabolism programs approaching clinical studies. It applies its integrated discovery platform to develop drugs for challenging diseases.

4 investors

Kamau Therapeutics develops targeted gene integration therapies to treat serious and life-threatening genetic diseases. The company is a clinical-stage biotech firm focused on next-generation gene correction.

4 investors

Karoo provides value-based care solutions for cardiology networks, health systems, and health plans, combining on-site and virtual care teams with proprietary technology to improve patient outcomes and reduce costs. The platform integrates patient data management, care coordination, and social determinants of health support to transition providers from fee-for-service to value-based care models.

4 investors

Kate Farms makes plant-based nutritional shakes and formula products aimed at supporting digestion, tolerance, and overall health for people managing their nutrition and health needs. The company sells its products directly to consumers and is recommended by doctors for plant-based nutrition.

4 investors

The site is a Vietnamese-language affiliate/review portal that ranks and rates online lottery ("lô đề") betting operators, offering comparisons of payout ratios, licensing, payment methods, and security. It targets Vietnamese online gamblers looking to choose betting sites.

4 investors

Kento provides a continuous cardiovascular monitoring and management platform that combines AI-powered risk scoring with clinical expertise to enable proactive heart care for hospitals, insurers, and patients. The platform captures real-time vitals and behavioral signals to predict and prevent adverse cardiac events.

4 investors

KeyCare builds virtual care technology and telehealth solutions to extend health system capacity and improve access to healthcare. The company serves hospitals and health systems seeking integrated virtual care capabilities.

4 investors

KinderFarms makes children's OTC medicine and hydration products, such as electrolyte solutions, formulated with cleaner ingredients like zinc, dextrose, and electrolytes and without artificial dyes. The company sells consumer health products aimed at parents seeking effective, minimal-ingredient options for their kids.

4 investors

Kismet is a platform that matches people using Australia's National Disability Insurance Scheme (NDIS) with suitable service providers and offers tools for NDIS budgeting, financial management, and plan navigation. It serves NDIS participants and works with policymakers on care sector innovation in Australia.

4 investors

Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools. The platform serves hospital pharmacies to automate workflows, integrate operational data, and improve efficiency.

4 investors

Kivu Bioscience is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for oncology, using site-specific conjugation technology to create more stable and homogeneous cancer therapies with reduced off-tumor toxicity. Its pipeline of ADC candidates targets solid tumors and other cancer indications.

4 investors

KnownWell provides virtual and in-person weight-inclusive healthcare for patients with overweight and obesity. The company delivers clinically sound information through shared decision-making to help patients achieve their health goals.

4 investors

Koa Health develops a unified digital mental health platform that delivers evidence-based treatment programs and clinical interventions. The company serves healthcare organizations, medical institutions, and patients seeking comprehensive mental health care validated through randomized controlled trials and clinical research.

4 investors

Koltin operates a membership program that includes major medical expense insurance underwritten by BBVA Seguros Salud, offering preventive health services, community access, and controlled annual renewal increases based on preventive care.

4 investors

Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis. Its products are aimed at healthcare professionals and patients, including veterans with chronic edema.

4 investors

Ladder Health provides virtual pediatric therapy services, including speech, occupational, and physical therapy delivered by clinicians to children and families at home. The service is evidence-based, developed at Boston Children's Hospital, and designed to help children develop communication, motor, social, and cognitive skills.

4 investors

Laguna Health provides a conversational AI platform for healthcare care teams and care managers that reduces administrative work by automating post-call documentation, surfacing real-time conversation insights, and offering dynamic care pathways. It also gives supervisors a performance dashboard that captures and analyzes calls to support team quality assurance and coaching.

4 investors

Latica provides a secure platform for accessing structured and unstructured real-world patient data, along with analytics and medical intelligence, focused on specialty medicine. It serves healthcare providers, medtech companies, and life science organizations for uses such as clinical trials, AI model development, and improving patient care.

4 investors

Latigo Bio is a clinical-stage biopharmaceutical company developing non-opioid pain medicines intended to block pain transmission without addiction risk. It targets the pain management therapeutic market in the United States.

4 investors

Laverock develops programmable engineered cell therapies that control gene expression based on cell identity and environment, activating only in the target cell population and tuning expression to precise levels. The company applies its gene-regulation platforms to an internal advanced therapy pipeline and pursues outlicensing and partnerships for additional therapeutic and non-therapeutic applications.

4 investors

Lenoss develops products aimed at advancing a physiological treatment pathway, supported by a team of industry professionals and clinical advisors. The company operates in the medical field with a focus on clinical treatment solutions.

4 investors

Leona is a platform that integrates with WhatsApp to help healthcare professionals—particularly doctors and their teams—manage patient communications, automate appointment scheduling, and handle administrative tasks. It enables practitioners to organize conversations by clinic or patient type, prioritize messages, transcribe voice notes, and collaborate with team members while maintaining patient privacy.

4 investors

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission. The company works on broadly protective antiviral products aimed at addressing endemic and pandemic respiratory threats.

4 investors